{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:00Z","timestamp":1786982760996,"version":"build-2736575974"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s40263-022-00929-x","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T15:02:39Z","timestamp":1654873359000},"page":"721-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Pharmacological Management of Nightmares Associated with Posttraumatic Stress Disorder"],"prefix":"10.1007","volume":"36","author":[{"given":"Christoff","family":"Geldenhuys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3884-4754","authenticated-orcid":false,"given":"Leigh L.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4030-3060","authenticated-orcid":false,"given":"Petrus","family":"Steyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5118-786X","authenticated-orcid":false,"given":"Soraya","family":"Seedat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"929_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-pharmtox-010818-021701","volume":"59","author":"CG Abdallah","year":"2019","unstructured":"Abdallah CG, Averill LA, Akiki TJ, Raza M, Averill CL, Gomaa H, et al. The neurobiology and pharmacotherapy of posttraumatic stress disorder. Annu Rev Pharmacol Toxicol. 2019;59:171\u201389.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"929_CR2","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington DC: American Psychiatric Association; 2013.","edition":"5"},{"key":"929_CR3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cpr.2012.06.002","volume":"32","author":"MD Casement","year":"2012","unstructured":"Casement MD, Swanson LM. A meta-analysis of imagery rehearsal for post-trauma nightmares: effects on nightmare frequency, sleep quality, and posttraumatic stress. Clin Psychol Rev. 2012;32:566\u201374.","journal-title":"Clin Psychol Rev"},{"key":"929_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-018-0916-9","author":"PJ Colvonen","year":"2018","unstructured":"Colvonen PJ, Straus LD, Stepnowsky C, McCarthy MJ, Goldstein LA, Norman SB. Recent advancements in treating sleep disorders in co-occurring PTSD. Curr Psychiatry Rep. 2018. https:\/\/doi.org\/10.1007\/s11920-018-0916-9.","journal-title":"Curr Psychiatry Rep"},{"key":"929_CR5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/sleep\/33.12.1615","volume":"33","author":"AD Seelig","year":"2010","unstructured":"Seelig AD, Jacobson IG, Smith B, Hooper TI, Boyko EJ, Gackstetter GD, et al. Sleep patterns before, during, and after deployment to Iraq and Afghanistan. Sleep. 2010;33:1615\u201322.","journal-title":"Sleep"},{"key":"929_CR6","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.5665\/sleep.5044","volume":"38","author":"MM Jenkins","year":"2015","unstructured":"Jenkins MM, Colvonen PJ, Norman SB, Afari N, Allard CB, Drummond SPA. Prevalence and mental health correlates of insomnia in first-encounter veterans with and without military sexual trauma. Sleep. 2015;38:1547\u201354.","journal-title":"Sleep"},{"key":"929_CR7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1037\/a0034958","volume":"11","author":"TR Plumb","year":"2014","unstructured":"Plumb TR, Peachey JT, Zelman DC. Sleep disturbance is common among service members and veterans of Operations Enduring Freedom and Iraqi Freedom. Psychol Serv. 2014;11:209\u201319.","journal-title":"Psychol Serv"},{"key":"929_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2147\/NSS.S260734","volume":"12","author":"DG Maguire","year":"2020","unstructured":"Maguire DG, Ruddock MW, Milanak ME, Moore T, Cobice D, Armour C. Sleep, a Governor of Morbidity in PTSD: a systematic review of biological markers in PTSD-related sleep disturbances. Nat Sci Sleep. 2020;12:545\u201362.","journal-title":"Nat Sci Sleep."},{"key":"929_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41386-019-0486-5","volume":"45","author":"A Richards","year":"2020","unstructured":"Richards A, Kanady J, Neylan T. Sleep disturbance in PTSD and other anxiety-related disorders: an updated review\u00a0of clinical features,\u00a0physiological characteristics, and psychological and neurobiological mechanisms. Neuropsychopharmacology. 2020;45:55\u201373.","journal-title":"Neuropsychopharmacology"},{"key":"929_CR10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/1363461517746314","volume":"54","author":"H Sandahl","year":"2017","unstructured":"Sandahl H, Vindbjerg E, Carlsson J. Treatment of sleep disturbances in refugees suffering from post-traumatic stress disorder. Transcult Psychiatry. 2017;54:806\u201323.","journal-title":"Transcult Psychiatry"},{"key":"929_CR11","doi-asserted-by":"crossref","unstructured":"Gallegos AM, Trabold N, Cerulli C, Pigeon WR. Sleep and interpersonal violence: a systematic review. Trauma Violence Abuse. 2021;22:359\u201369.","DOI":"10.1177\/1524838019852633"},{"key":"929_CR12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0005-7967(00)00084-X","volume":"39","author":"D Forbes","year":"2001","unstructured":"Forbes D, Creamer M, Biddle D. The validity of the PTSD checklist as a measure of symptomatic change in combat-related PTSD. Behav Res Ther. 2001;39:977\u201386.","journal-title":"Behav Res Ther"},{"key":"929_CR13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cpr.2015.09.005","volume":"43","author":"FY-Y Ho","year":"2016","unstructured":"Ho FY-Y, Chan CS, Tang KN-S. Cognitive-behavioral therapy for sleep disturbances in treating posttraumatic stress disorder symptoms: a meta-analysis of randomized controlled trials. Clin Psychol Rev. 2016;43:90\u2013102.","journal-title":"Clin Psychol Rev"},{"key":"929_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11920-018-0971-2","volume":"20","author":"SH Waltman","year":"2018","unstructured":"Waltman SH, Shearer D, Moore BA. Management of post-traumatic nightmares: a review of pharmacologic and nonpharmacologic treatments since 2013. Curr Psychiatry Rep. 2018;20:108. https:\/\/doi.org\/10.1007\/s11920-018-0971-2.","journal-title":"Curr Psychiatry Rep"},{"key":"929_CR15","doi-asserted-by":"crossref","unstructured":"Nielsen T, Levin R. Nightmares: a new neurocognitive model. Sleep Med Rev. 2007;11:295\u2013310.","DOI":"10.1016\/j.smrv.2007.03.004"},{"key":"929_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00201","author":"T Nielsen","year":"2017","unstructured":"Nielsen T. The stress acceleration hypothesis of nightmares. Front Neurol. 2017. https:\/\/doi.org\/10.3389\/fneur.2017.00201.","journal-title":"Front Neurol"},{"key":"929_CR17","doi-asserted-by":"crossref","unstructured":"Belleville G, Guay S, Marchand A. Persistence of sleep disturbances following cognitive-behavior therapy for posttraumatic stress disorder. J Psychosom Res. 2011;70:318\u201327.","DOI":"10.1016\/j.jpsychores.2010.09.022"},{"key":"929_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1176\/appi.neuropsych.13010006","volume":"26","author":"BW Writer","year":"2014","unstructured":"Writer BW, Meyer EG, Schillerstrom JE. Prazosin for military combat-related PTSD nightmares: a critical review. J Neuropsychiatry Clin Neurosci. 2014;26:24\u201333.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"929_CR19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3928\/00485713-20090514-02","volume":"39","author":"A Germain","year":"2009","unstructured":"Germain A. Sleep disturbances in post traumatic stress disorder. Psychiatric Ann. 2009;39:335\u201341.","journal-title":"Psychiatric Ann"},{"key":"929_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0827-1","author":"K Miller","year":"2017","unstructured":"Miller K, Brownlow J, Woodward S, Gehrman P. Sleep and dreaming in posttraumatic stress disorder. Curr Psychiatry Rep. 2017. https:\/\/doi.org\/10.1007\/s11920-017-0827-1.","journal-title":"Curr Psychiatry Rep"},{"key":"929_CR21","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291721002075","author":"T M\u00e4der","year":"2021","unstructured":"M\u00e4der T, Oliver K, Daffre C, Kim S, Orr S, Lasko N, et al. Autonomic activity, posttraumatic and nontraumatic nightmares, and PTSD after trauma exposure. Psychol Med. 2021. https:\/\/doi.org\/10.1017\/S0033291721002075.","journal-title":"Psychol Med"},{"key":"929_CR22","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.5664\/jcsm.7178","volume":"14","author":"TI Morgenthaler","year":"2018","unstructured":"Morgenthaler TI, Auerbach S, Casey KR, Kristo D, Maganti R, Ramar K, et al. Position paper for the treatment of nightmare disorder in adults: an American Academy of Sleep Medicine Position Paper. J Clin Sleep Med. 2018;14:1041\u201355.","journal-title":"J Clin Sleep Med"},{"key":"929_CR23","doi-asserted-by":"crossref","unstructured":"Collen JF, Williams SG, Lettieri CJ. Doomed to repeat history: the burden of trauma-related nightmares in military personnel. J Clin Sleep Med. 2018;14:303\u20135.","DOI":"10.5664\/jcsm.6964"},{"key":"929_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70866-6","author":"LM Harris","year":"2020","unstructured":"Harris LM, Huang X, Linthicum KP, Bryen CP, Ribeiro JD. Sleep disturbances as risk factors for suicidal thoughts and behaviours: a meta-analysis of longitudinal studies. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-70866-6.","journal-title":"Sci Rep"},{"key":"929_CR25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/15402002.2020.1822360","volume":"19","author":"H Khazaie","year":"2021","unstructured":"Khazaie H, Zakiei A, McCall WV, Noori K, Rostampour M, Sadeghi Bahmani D, et al. Relationship between sleep problems and self-injury: a systematic review. Behav Sleep Med. 2021;19:689\u2013704.","journal-title":"Behav Sleep Med"},{"key":"929_CR26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40675-018-0119-2","volume":"4","author":"TD Rachakonda","year":"2018","unstructured":"Rachakonda TD, Balba NM, Lim MM. Trauma-associated sleep disturbances: a distinct sleep disorder? Curr Sleep Med Rep. 2018;4:143\u20138.","journal-title":"Curr Sleep Med Rep."},{"key":"929_CR27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.smrv.2017.01.004","volume":"37","author":"V Mysliwiec","year":"2018","unstructured":"Mysliwiec V, Brock MS, Creamer JL, O\u2019Reilly BM, Germain A, Roth BJ. Trauma associated sleep disorder: a parasomnia induced by trauma. Sleep Med Rev. 2018;37:94\u2013104.","journal-title":"Sleep Med Rev"},{"key":"929_CR28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.5664\/jcsm.4692","volume":"11","author":"PJ Colvonen","year":"2015","unstructured":"Colvonen PJ, Masino T, Drummond SPA, Myers US, Angkaw AC, Norman SB. Obstructive sleep apnea and posttraumatic stress disorder among OEF\/OIF\/OND veterans. J Clin Sleep Med. 2015;11:513\u20138.","journal-title":"J Clin Sleep Med"},{"key":"929_CR29","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.3390\/jcm10184175","volume":"10","author":"A Martin","year":"2021","unstructured":"Martin A, Naunton M, Kosari S, Peterson G, Thomas J, Christenson JK. Treatment guidelines for PTSD: a systematic review. J Clin Med. 2021;10:4175.","journal-title":"J Clin Med"},{"key":"929_CR30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jcpt.13274","volume":"46","author":"A Martin","year":"2021","unstructured":"Martin A, Kosari S, Peterson GM, Thomas J, Morris P, Naunton M. Pharmacological management of post-traumatic stress disorder and its associated nightmares: a survey of psychiatrists. J Clin Pharm Ther. 2021;46:158\u201365.","journal-title":"J Clin Pharm Ther"},{"key":"929_CR31","doi-asserted-by":"crossref","unstructured":"Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR, et al. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:169\u201380.","DOI":"10.1016\/j.pnpbp.2008.12.004"},{"key":"929_CR32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1176\/appi.ajp.2012.12040432","volume":"170","author":"A Germain","year":"2013","unstructured":"Germain A. Sleep disturbances as the hallmark of PTSD: where are we now? Am J Psychiatry. 2013;170:372\u201382.","journal-title":"Am J Psychiatry"},{"key":"929_CR33","doi-asserted-by":"crossref","unstructured":"Davidson JRT, Landerman LR, Farfel GM, Clary CM. Characterizing the effects of sertraline in post-traumatic stress disorder. Psychological Medicine [Internet]. 2002;32:661\u201370. https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291702005469\/type\/journal_article.","DOI":"10.1017\/S0033291702005469"},{"key":"929_CR34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hup.465","volume":"18","author":"JF Pagel","year":"2003","unstructured":"Pagel JF, Helfter P. Drug induced nightmares\u2014an etiology based review. Hum psychopharmacol. 2003;18:59\u201367.","journal-title":"Hum psychopharmacol"},{"key":"929_CR35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1023\/A:1011100420978","volume":"14","author":"TC Neylan","year":"2001","unstructured":"Neylan TC, Metzler TJ, Schoenfeld FB, Weiss DS, Lenoci M, Best SR, et al. Fluvoxamine and sleep disturbances in posttraumatic stress disorder. J Trauma Stress. 2001;14:461\u20137.","journal-title":"J Trauma Stress"},{"key":"929_CR36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000288593","volume":"57","author":"M de Boer","year":"1992","unstructured":"de Boer M, Op den Velde W, Falger PJ, Hovens JE, de Groen JH, van Duijn H. Fluvoxamine treatment for chronic PTSD: a pilot study. Psychother Psychosom. 1992;57:158\u201363.","journal-title":"Psychother Psychosom"},{"key":"929_CR37","doi-asserted-by":"crossref","unstructured":"Meltzer-Brody S, Connor KM, Churchill E, Davidson JRT. Symptom-specific effects of fluoxetine in post-traumatic stress disorder. International Clinical Psychopharmacology [Internet]. 2000;15:227\u201331. http:\/\/journals.lww.com\/00004850-200015040-00006.","DOI":"10.1097\/00004850-200015040-00006"},{"key":"929_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1017\/S1461145708008961","volume":"12","author":"DJ Stein","year":"2009","unstructured":"Stein DJ, Pedersen R, Rothbaum BO, Baldwin DS, Ahmed S, Musgnung J, et al. Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis. Int J Neuropsychopharmacol. 2009;12:23. https:\/\/doi.org\/10.1017\/S1461145708008961.","journal-title":"Int J Neuropsychopharmacol"},{"key":"929_CR39","unstructured":"Villarreal G, Ca\u00f1ive JM, Calais LA, Toney G, Smith AK. Duloxetine in military posttraumatic stress disorder. Psychopharmacol Bull. 2010;43:26\u201334."},{"key":"929_CR40","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1176\/ajp.142.8.956","volume":"142","author":"JK Boehnlein","year":"1985","unstructured":"Boehnlein JK, Kinzie JD, Ben R, Fleck J. One-year follow-up study of posttraumatic stress disorder among survivors of Cambodian concentration camps. Am J Psychiatry. 1985;142:956\u20139. https:\/\/doi.org\/10.1176\/ajp.142.8.956.","journal-title":"Am J Psychiatry"},{"key":"929_CR41","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1001\/archpsyc.1981.01780290074008","volume":"38","author":"GL Hogben","year":"1981","unstructured":"Hogben GL. Treatment of traumatic war neurosis with phenelzine. Arch Gen Psychiatry. 1981;38:440. https:\/\/doi.org\/10.1001\/archpsyc.1981.01780290074008.","journal-title":"Arch Gen Psychiatry"},{"key":"929_CR42","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/archpsyc.1987.01800230056010","volume":"44","author":"B Lerer","year":"1987","unstructured":"Lerer B, Bleich A, Kotler M, Garb R, Hertzberg M, Levin B. Posttraumatic stress disorder in Israeli combat veterans. Effect of phenelzine treatment. Arch Gen Psychiatry. 1987;44:976.","journal-title":"Arch Gen Psychiatry"},{"key":"929_CR43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2001-15871","volume":"34","author":"MD Warner","year":"2001","unstructured":"Warner MD, Dorn MR, Peabody CA. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. Pharmacopsychiatry. 2001;34:128\u201331.","journal-title":"Pharmacopsychiatry"},{"key":"929_CR44","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1513\/AnnalsATS.201408-399OC","volume":"12","author":"ET Smales","year":"2015","unstructured":"Smales ET, Edwards BA, Deyoung PN, McSharry DG, Wellman A, Velasquez A, et al. Trazodone Effects on Obstructive Sleep Apnea and Non-REM Arousal Threshold. Ann Am Thorac Soc. 2015;12:758\u201364.","journal-title":"Ann Am Thorac Soc"},{"key":"929_CR45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-199903000-00001","volume":"14","author":"R Hidalgo","year":"1999","unstructured":"Hidalgo R, Hertzberg MA, Mellman T, Petty F, Tucker P, Weisler R, et al. Nefazodone in post-traumatic stress disorder: results from six open-label trials. Int Clin Psychopharmacol. 1999;14:61\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"929_CR46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4088\/JCP.v64n0415","volume":"64","author":"TC Neylan","year":"2003","unstructured":"Neylan TC, Lenoci M, Maglione ML, Rosenlicht NZ, Leykin Y, Metzler TJ, et al. The effect of nefazodone on subjective and objective sleep quality in posttraumatic stress disorder. J Clin Psychiatry. 2003;64:445\u201350.","journal-title":"J Clin Psychiatry"},{"key":"929_CR47","first-page":"19","volume":"37","author":"J Rosack","year":"2002","unstructured":"Rosack J. FDA orders liver warning on nefazodone labels. Psych News. 2002;37:19\u201325.","journal-title":"Psych News."},{"key":"929_CR48","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1176\/appi.ajp.159.11.1948-a","volume":"159","author":"JD Lewis","year":"2002","unstructured":"Lewis JD. Mirtazapine for PTSD nightmares. Am J Psychiatry. 2002;159:1948-a-1949. https:\/\/doi.org\/10.1176\/appi.ajp.159.11.1948-a.","journal-title":"Am J Psychiatry"},{"key":"929_CR49","first-page":"1","volume":"25","author":"C Buhmann","year":"2015","unstructured":"Buhmann C, Mortensen EL, Nordentoft M, Ryberg J, Ekstr\u00f8m M. Follow-up study of the treatment outcomes at a psychiatric trauma clinic for refugees. Torture. 2015;25:1\u201316.","journal-title":"Torture"},{"key":"929_CR50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1017\/S1092852920001121","volume":"26","author":"C Reist","year":"2021","unstructured":"Reist C, Streja E, Tang CC, Shapiro B, Mintz J, Hollifield M. Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis. CNS spectr. 2021;26:338\u201344.","journal-title":"CNS spectr"},{"key":"929_CR51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.pra.0000364287.63210.92","volume":"15","author":"L Boynton","year":"2009","unstructured":"Boynton L, Bentley J, Strachan E, Barbato A, Raskind M. Preliminary findings concerning the use of prazosin for the treatment of posttraumatic nightmares in a refugee population. J Psychiatr Pract. 2009;15:454\u20139.","journal-title":"J Psychiatr Pract"},{"key":"929_CR52","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1176\/appi.ajp.2013.12081133","volume":"170","author":"MA Raskind","year":"2013","unstructured":"Raskind MA, Peterson K, Williams T, Hoff DJ, Hart K, Holmes H, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013;170:1003\u201310.","journal-title":"Am J Psychiatry"},{"key":"929_CR53","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biopsych.2007.07.001","volume":"63","author":"FB Taylor","year":"2008","unstructured":"Taylor FB, Martin P, Thompson C, Williams J, Mellman TA, Gross C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008;63:629\u201332.","journal-title":"Biol Psychiatry"},{"key":"929_CR54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychores.2011.11.010","volume":"72","author":"A Germain","year":"2012","unstructured":"Germain A, Richardson R, Moul DE, Mammen O, Haas G, Forman SD, et al. Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans. J Psychosom Res. 2012;72:89\u201396.","journal-title":"J Psychosom Res"},{"key":"929_CR55","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.biopsych.2006.06.032","volume":"61","author":"MA Raskind","year":"2007","unstructured":"Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61:928\u201334.","journal-title":"Biol Psychiatry"},{"key":"929_CR56","doi-asserted-by":"crossref","unstructured":"Aurora RN, Zak RS, Auerbach SH, Casey KR, Chowdhuri S, Karippot A, et al. Best practice guide for the treatment of nightmare disorder in adults. J Clin Sleep Med. 2010;6:389\u2013401.","DOI":"10.5664\/jcsm.27883"},{"key":"929_CR57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.genhosppsych.2015.10.007","volume":"39","author":"D Khachatryan","year":"2016","unstructured":"Khachatryan D, Groll D, Booij L, Sepehry AA, Sch\u00fctz CG. Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials. Gen Hosp Psychiatry. 2016;39:46\u201352.","journal-title":"Gen Hosp Psychiatry"},{"key":"929_CR58","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1101\/lm.030007.112","volume":"20","author":"L Gazarini","year":"2013","unstructured":"Gazarini L, Stern CAJ, Carobrez AP, Bertoglio LJ. Enhanced noradrenergic activity potentiates fear memory consolidation and reconsolidation by differentially recruiting \u03b11- and \u03b2-adrenergic receptors. Learn Mem. 2013;20:210\u20139.","journal-title":"Learn Mem"},{"key":"929_CR59","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1507598","volume":"378","author":"MA Raskind","year":"2018","unstructured":"Raskind MA, Peskind ER, Chow B, Harris C, Davis-Karim A, Holmes HA, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018;378:507\u201317.","journal-title":"N Engl J Med"},{"key":"929_CR60","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.sleep.2019.06.010","volume":"67","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ren R, Sanford LD, Yang L, Ni Y, Zhou J, et al. The effects of prazosin on sleep disturbances in post-traumatic stress disorder: a systematic review and meta-analysis. Sleep Med. 2020;67:225\u201331.","journal-title":"Sleep Med"},{"key":"929_CR61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/WNF.0000000000000077","volume":"38","author":"A Nirmalani-Gandhy","year":"2015","unstructured":"Nirmalani-Gandhy A, Sanchez D, Catalano G. Terazosin for the treatment of trauma-related nightmares. Clin Neuropharmacol. 2015;38:109\u201311.","journal-title":"Clin Neuropharmacol"},{"key":"929_CR62","unstructured":"Salviati M, Pallagrosi M, Valeriani G, Carlone C, Todini L, Biondi M. On the role of noradrenergic system in PTSD and related sleep disturbances. The use of terazosin in PTSD related nightmares: a case report. Clin Ter. 2013;164:133\u20137."},{"key":"929_CR63","first-page":"26","volume":"50","author":"S Roepke","year":"2017","unstructured":"Roepke S, Danker-Hopfe H, Repantis D, Behnia B, Bernard F, Hansen M-L, et al. Doxazosin, an \u03b1-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and\/or Borderline Personality Disorder: a Chart Review. Pharmacopsychiatry. 2017;50:26\u201331.","journal-title":"Pharmacopsychiatry"},{"key":"929_CR64","doi-asserted-by":"crossref","unstructured":"Calegaro VC, Mosele PHC, Duarte e Souza I, da Silva EM, Trindade JP. Treating nightmares in PTSD with doxazosin: a report of three cases. Braz J Psychiatry. 2019;41:189\u201390. http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-44462019000200013&tlng=en","DOI":"10.1590\/1516-4446-2018-0292"},{"key":"929_CR65","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3928\/00485713-20160728-01","volume":"46","author":"C Smith","year":"2016","unstructured":"Smith C, Koola MM. Evidence for using doxazosin in the treatment of posttraumatic stress disorder. Psychiatr Ann. 2016;46:553\u20135.","journal-title":"Psychiatr Ann"},{"key":"929_CR66","doi-asserted-by":"crossref","unstructured":"Detweiler M, Pagadala B, Candelario J, Boyle J, Detweiler J, Lutgens B. Treatment of post-traumatic stress disorder nightmares at a Veterans affairs medical center. J Clin Med. 2016;5:117. http:\/\/www.mdpi.com\/2077-0383\/5\/12\/117","DOI":"10.3390\/jcm5120117"},{"key":"929_CR67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2190\/PM.44.2.g","volume":"44","author":"A Alao","year":"2012","unstructured":"Alao A, Selvarajah J, Razi S. The use of clonidine in the treatment of nightmares among patients with co-morbid PTSD and traumatic brain injury. Int J Psychiatry Med. 2012;44:165\u20139.","journal-title":"Int J Psychiatry Med"},{"key":"929_CR68","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2165\/00023210-200620070-00003","volume":"20","author":"MJ Maher","year":"2006","unstructured":"Maher MJ, Rego SA, Asnis GM. Sleep disturbances in patients with post-traumatic stress disorder. CNS Drugs. 2006;20:567\u201390. https:\/\/doi.org\/10.2165\/00023210-200620070-00003.","journal-title":"CNS Drugs"},{"key":"929_CR69","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00003495-200464040-00004","volume":"64","author":"GM Asnis","year":"2004","unstructured":"Asnis GM, Kohn SR, Henderson M, Brown NL. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations. Drugs. 2004;64:383\u2013404.","journal-title":"Drugs"},{"key":"929_CR70","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/JCP.0b013e3181faa597","volume":"30","author":"N Khachiyants","year":"2010","unstructured":"Khachiyants N, Ali R, Kovesdy CP, Detweiler JG, Kim KY, Detweiler MB. Effectiveness of risperidone for the treatment of nightmares in Veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2010;30:735\u20137.","journal-title":"J Clin Psychopharmacol"},{"key":"929_CR71","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/da.20187","volume":"23","author":"D David","year":"2006","unstructured":"David D, de Faria L, Mellman TA. Adjunctive risperidone treatment and sleep symptoms in combat veterans with chronic PTSD. Depress Anxiety. 2006;23:489\u201391.","journal-title":"Depress Anxiety"},{"key":"929_CR72","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4088\/JCP.14m09585","volume":"77","author":"JH Krystal","year":"2016","unstructured":"Krystal JH, Pietrzak RH, Rosenheck RA, Cramer JA, Vessicchio J, Jones KM, et al. Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504. J Clin Psychiatry. 2016;77:483\u201391.","journal-title":"J Clin Psychiatry"},{"key":"929_CR73","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1034\/j.1600-0447.2003.00065.x","volume":"107","author":"M Jakovljevi\u0107","year":"2003","unstructured":"Jakovljevi\u0107 M, Sagud M, Mihaljevi\u0107-Peles A. Olanzapine in the treatment-resistant, combat-related PTSD\u2014a series of case reports. Acta Psychiatr Scand. 2003;107:394\u20136.","journal-title":"Acta Psychiatr Scand"},{"key":"929_CR74","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1176\/appi.ajp.159.10.1777","volume":"159","author":"MB Stein","year":"2002","unstructured":"Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002;159:1777\u20139.","journal-title":"Am J Psychiatry"},{"key":"929_CR75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004850-200107000-00003","volume":"16","author":"MI Butterfield","year":"2001","unstructured":"Butterfield MI, Becker ME, Connor KM, Sutherland S, Churchill LE, Davidson JR. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16:197\u2013203.","journal-title":"Int Clin Psychopharmacol"},{"key":"929_CR76","doi-asserted-by":"crossref","unstructured":"Robert S, Hamner MB, Kose S, Ulmer HG, Deitsch SE, Lorberbaum JP. Quetiapine improves sleep disturbances in combat Veterans with PTSD. J Clin Psychopharmacol. 2005;25:387\u20138. https:\/\/journals.lww.com\/00004714-200508000-00017","DOI":"10.1097\/01.jcp.0000169624.37819.60"},{"key":"929_CR77","doi-asserted-by":"crossref","unstructured":"Byers MG, Allison KM, Wendel CS, Lee JK. Prazosin Versus quetiapine for nighttime posttraumatic stress disorder symptoms in Veterans. J Clin Psychopharmacol. 2010;30:225\u20139. https:\/\/journals.lww.com\/00004714-201006000-00002","DOI":"10.1097\/JCP.0b013e3181dac52f"},{"key":"929_CR78","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.yic.0000185021.48279.00","volume":"21","author":"MT Lambert","year":"2006","unstructured":"Lambert MT. Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans. Int Clin Psychopharmacol. 2006;21:185\u20137.","journal-title":"Int Clin Psychopharmacol"},{"key":"929_CR79","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cpr.2009.09.001","volume":"29","author":"J Cukor","year":"2009","unstructured":"Cukor J, Spitalnick J, Difede J, Rizzo A, Rothbaum B. Emerging treatments for PTSD. Clin Psychol Rev. 2009;29:715\u201326.","journal-title":"Clin Psychol Rev"},{"key":"929_CR80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00543712","volume":"28","author":"TA Betts","year":"1985","unstructured":"Betts TA, Alford C. Beta-blockers and sleep: a controlled trial. Eur J Clin Pharmacol. 1985;28:65\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"929_CR81","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hup.1171","volume":"26","author":"MU Shad","year":"2011","unstructured":"Shad MU, Suris AM, North CS. Novel combination strategy to optimize treatment for PTSD. Hum Psychopharmacol Clin Exp. 2011;26:4\u201311. https:\/\/doi.org\/10.1002\/hup.1171.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"929_CR82","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1682\/JRRD.2011.09.0164","volume":"49","author":"FB Schoenfeld","year":"2012","unstructured":"Schoenfeld FB, Deviva JC, Manber R. Treatment of sleep disturbances in posttraumatic stress disorder: a review. J Rehabil Res Dev. 2012;49:729.","journal-title":"J Rehabil Res Dev"},{"key":"929_CR83","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1345\/aph.1E043","volume":"38","author":"ME Cates","year":"2004","unstructured":"Cates ME, Bishop MH, Davis LL, Lowe JS, Woolley TW. Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. Ann Pharmacother. 2004;38:1395\u20139.","journal-title":"Ann Pharmacother"},{"key":"929_CR84","first-page":"236","volume":"51","author":"P Braun","year":"1990","unstructured":"Braun P, Greenberg D, Dasberg H, Lerer B. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry. 1990;51:236\u20138.","journal-title":"J Clin Psychiatry"},{"key":"929_CR85","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0447.1983.tb00336.x","volume":"67","author":"PA Ellingsen","year":"1983","unstructured":"Ellingsen PA. Double-blind trial of triazolam 0.5 mg vs. nitrazepam 5 mg in outpatients. Acta psychiatr Scand. 1983;67:154\u20138.","journal-title":"Acta psychiatr Scand"},{"key":"929_CR86","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1176\/ps.50.3.421","volume":"50","author":"ME Dieperink","year":"1999","unstructured":"Dieperink ME, Drogemuller L. Zolpidem for insomnia related to PTSD. Psychiatr Serv. 1999;50:421.","journal-title":"Psychiatr Serv"},{"key":"929_CR87","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/0269881109106927","volume":"24","author":"DJ Nutt","year":"2010","unstructured":"Nutt DJ, Stahl SM. Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2010;24:1601\u201312.","journal-title":"J Psychopharmacol"},{"key":"929_CR88","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/00207140802039672","volume":"56","author":"EG Abramowitz","year":"2008","unstructured":"Abramowitz EG, Barak Y, Ben-Avi I, Knobler HY. Hypnotherapy in the treatment of chronic combat-related PTSD patients suffering from insomnia: a randomized, zolpidem-controlled clinical trial. Int J Clin Exp Hypn. 2008;56:270\u201380.","journal-title":"Int J Clin Exp Hypn"},{"key":"929_CR89","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/10401230109148960","volume":"13","author":"MB Hamner","year":"2001","unstructured":"Hamner MB, Brodrick PS, Labbate LA. Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy. Ann Clin Psychiatry. 2001;13:141\u20136.","journal-title":"Ann Clin Psychiatry"},{"key":"929_CR90","doi-asserted-by":"publisher","unstructured":"Berlin RK, Butler PM, Perloff MD. Gabapentin therapy in psychiatric disorders: a systematic review. Prim Care Companion CNS Disord. 2015;17. https:\/\/doi.org\/10.4088\/PCC.15r01821.","DOI":"10.4088\/PCC.15r01821"},{"key":"929_CR91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4088\/JCP.v63n0104","volume":"63","author":"J Berlant","year":"2002","unstructured":"Berlant J, van Kammen DP. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry. 2002;63:15\u201320.","journal-title":"J Clin Psychiatry"},{"key":"929_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-4-24","author":"JL Berlant","year":"2004","unstructured":"Berlant JL. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder. BMC Psychiatry. 2004. https:\/\/doi.org\/10.1186\/1471-244X-4-24.","journal-title":"BMC Psychiatry"},{"key":"929_CR93","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1345\/aph.1L578","volume":"43","author":"CP Alderman","year":"2009","unstructured":"Alderman CP, McCarthy LC, Condon JT, Marwood AC, Fuller JR. Topiramate in combat-related posttraumatic stress disorder. Ann Pharmacother. 2009;43:635\u201341. https:\/\/doi.org\/10.1345\/aph.1L578.","journal-title":"Ann Pharmacother"},{"key":"929_CR94","doi-asserted-by":"crossref","unstructured":"Tucker P, Trautman RP, Wyatt DB, Thompson J, Wu S-C, Capece JA, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder. J Clin Psychiatry. 2007;68:201\u20136. http:\/\/article.psychiatrist.com\/?ContentType=START&ID=10002930","DOI":"10.4088\/JCP.v68n0204"},{"key":"929_CR95","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2147\/NSS.S166089","volume":"10","author":"A El-Solh","year":"2018","unstructured":"El-Solh A. Management of Nightmares in patients with posttraumatic stress disorders: current perspectives. Nat Sci Sleep. 2018;10:409\u201320.","journal-title":"Nat Sci Sleep."},{"key":"929_CR96","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3109\/10401230209147455","volume":"14","author":"R Singareddy","year":"2002","unstructured":"Singareddy R, Baron R. Sleep in posttraumatic stress disorder. Ann Clin Psychiatry. 2002;14:661\u201370.","journal-title":"Ann Clin Psychiatry"},{"key":"929_CR97","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00004714-199910000-00023","volume":"19","author":"RD Clark","year":"1999","unstructured":"Clark RD, Canive JM, Calais LA, Qualls C, Brugger RD, Vosburgh TB. Cyproheptadine treatment of nightmares associated with posttraumatic stress disorder. J Clin Psychopharmacol. 1999;19:486\u20137.","journal-title":"J Clin Psychopharmacol"},{"key":"929_CR98","doi-asserted-by":"crossref","unstructured":"Ahmadpanah M, Sabzeiee P, Hosseini SM, Torabian S, Haghighi M, Jahangard L, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014;69:235\u201342. https:\/\/www.karger.com\/Article\/FullText\/362243","DOI":"10.1159\/000362243"},{"key":"929_CR99","doi-asserted-by":"crossref","unstructured":"Wells BG, Chu CC, Johnson R, Nasdahl C, Ayubi MA, Sewell E, et al. Buspirone in the treatment of posttraumatic stress disorder. Pharmacotherapy. 1991;11:340\u20133.","DOI":"10.1002\/j.1875-9114.1991.tb04299.x"},{"key":"929_CR100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401239409148837","volume":"6","author":"JD Duffy","year":"1994","unstructured":"Duffy JD, Malloy PF. Efficacy of buspirone in the treatment of posttraumatic stress disorder: an open trial. Ann Clin Psychiatry. 1994;6:33\u20137.","journal-title":"Ann Clin Psychiatry"},{"key":"929_CR101","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1254\/fpj.152.194","volume":"152","author":"K Fukunaga","year":"2018","unstructured":"Fukunaga K, Yabuki Y, Takahata I, Matsuo K. Neurological mechanism and therapeutic strategy for posttraumatic stress disorders. Nihon Yakurigaku Zasshi. 2018;152:194\u2013201.","journal-title":"Nihon Yakurigaku Zasshi."},{"key":"929_CR102","first-page":"241","volume":"24","author":"D de Berardis","year":"2012","unstructured":"de Berardis D, Serroni N, Marini S, Moschetta FS, Martinotti G, di Giannantonio M. Agomelatine for the treatment of posttraumatic stress disorder: a case report. Ann Clin Psychiatry. 2012;24:241\u20132.","journal-title":"Ann Clin Psychiatry"},{"key":"929_CR103","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1176\/appi.ajp.2020.20121677","volume":"178","author":"MB Stein","year":"2021","unstructured":"Stein MB, Simon NM. Ketamine for PTSD: Well, Isn\u2019t That Special. Am J Psychiatry. 2021;178:116\u20138.","journal-title":"Am J Psychiatry"},{"key":"929_CR104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.212305","volume":"8","author":"F Liriano","year":"2019","unstructured":"Liriano F, Hatten C, Schwartz TL. Ketamine as treatment for post-traumatic stress disorder: a review. Drugs Context. 2019;8:1\u20137.","journal-title":"Drugs Context."},{"key":"929_CR105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/jamapsychiatry.2014.1751","volume":"72","author":"A Feder","year":"2015","unstructured":"Feder A, Murrough J. Ketamine for posttraumatic stress disorder. JAMA Psychiat. 2015;72:95.","journal-title":"JAMA Psychiat"},{"key":"929_CR106","first-page":"385","volume":"23","author":"E Krediet","year":"2020","unstructured":"Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E. Reviewing the potential of psychedelics for the treatment of PTSD. Int J Psychopharmacol. 2020;23:385\u2013400.","journal-title":"Int J Psychopharmacol."},{"key":"929_CR107","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","volume":"71","author":"A Feder","year":"2014","unstructured":"Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder. JAMA Psychiat. 2014;71:681.","journal-title":"JAMA Psychiat"},{"key":"929_CR108","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1176\/appi.ajp.2020.20050596","volume":"178","author":"A Feder","year":"2021","unstructured":"Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, et al. A Randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. Am J Psych. 2021;178:193\u2013202.","journal-title":"Am J Psych"},{"key":"929_CR109","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2165\/11634390-000000000-00000","volume":"26","author":"G Sani","year":"2012","unstructured":"Sani G, Serra G, Kotzalidis GD, Romano S, Tamorri SM, Manfredi G, et al. The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence. CNS Drugs. 2012;26:663\u201390.","journal-title":"CNS Drugs"},{"key":"929_CR110","doi-asserted-by":"publisher","unstructured":"Battista MA, Hierholzer R, Khouzam HR, Barlow A, O\u2019Toole S. Pilot trial of memantine in the treatment of posttraumatic stress disorder. Psychiatry Interpersonal Biol Process. 2007;70:167\u201374. https:\/\/doi.org\/10.1521\/psyc.2007.70.2.167","DOI":"10.1521\/psyc.2007.70.2.167"},{"key":"929_CR111","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci. 1990;87:1932\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"929_CR112","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0269881111408958","volume":"26","author":"S Ruehle","year":"2012","unstructured":"Ruehle S, Rey AA, Remmers F, Lutz B. The endocannabinoid system in anxiety, fear memory and habituation. J Psychopharmacol. 2012;26:23\u201339.","journal-title":"J Psychopharmacol"},{"key":"929_CR113","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","volume":"15","author":"GA Fraser","year":"2009","unstructured":"Fraser GA. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Therap. 2009;15:84\u20138. https:\/\/doi.org\/10.1111\/j.1755-5949.2008.00071.x.","journal-title":"CNS Neurosci Therap."},{"key":"929_CR114","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","volume":"51","author":"R Jetly","year":"2015","unstructured":"Jetly R, Heber A, Fraser G, Boisvert D. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study. Psychoneuroendocrinology. 2015;51:585\u20138.","journal-title":"Psychoneuroendocrinology"},{"key":"929_CR115","doi-asserted-by":"crossref","first-page":"101339","DOI":"10.1016\/j.smrv.2020.101339","volume":"53","author":"AS Suraev","year":"2020","unstructured":"Suraev AS, Marshall NS, Vandrey R, McCartney D, Benson MJ, McGregor IS, et al. Cannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studies. Sleep Med Rev. 2020;53:101339.","journal-title":"Sleep Med Rev"},{"key":"929_CR116","doi-asserted-by":"crossref","unstructured":"Hindocha C, Cousijn J, Rall M, Bloomfield MAP. The effectiveness of cannabinoids in the treatment of posttraumatic stress disorder (PTSD): a systematic review. J Dual Diagn. 2020;16:120\u201339.","DOI":"10.1080\/15504263.2019.1652380"},{"key":"929_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32651-4","author":"P Berman","year":"2018","unstructured":"Berman P, Futoran K, Lewitus GM, Mukha D, Benami M, Shlomi T, et al. A new ESI-LC\/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis. Sci Rep. 2018. https:\/\/doi.org\/10.1038\/s41598-018-32651-4.","journal-title":"Sci Rep"},{"key":"929_CR118","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40261-014-0212-3","volume":"34","author":"P Roitman","year":"2014","unstructured":"Roitman P, Mechoulam R, Cooper-Kazaz R, Shalev A. Preliminary, open-label, pilot study of add-on oral \u03949-tetrahydrocannabinol in chronic post-traumatic stress disorder. Clin Drug Investig. 2014;34:587\u201391. https:\/\/doi.org\/10.1007\/s40261-014-0212-3.","journal-title":"Clin Drug Investig"},{"key":"929_CR119","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1089\/acm.2018.0437","volume":"25","author":"L Elms","year":"2019","unstructured":"Elms L, Shannon S, Hughes S, Lewis N. Cannabidiol in the treatment of post-traumatic stress disorder: a case series. J Alternative Complementary Med. 2019;25:392\u20137. https:\/\/doi.org\/10.1089\/acm.2018.0437.","journal-title":"J Alternative Complementary Med."},{"key":"929_CR120","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-019-1044-x","author":"I Hamilton","year":"2019","unstructured":"Hamilton I, Monaghan M. Cannabis and psychosis: are we any closer to understanding the relationship? Curr Psychiatry Rep. 2019. https:\/\/doi.org\/10.1007\/s11920-019-1044-x.","journal-title":"Curr Psychiatry Rep"},{"key":"929_CR121","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","volume":"11","author":"FX Vollenweider","year":"2010","unstructured":"Vollenweider FX, Kometer M. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci. 2010;11:642\u201351.","journal-title":"Nat Rev Neurosci"},{"key":"929_CR122","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23:3170.","journal-title":"Cell Rep"},{"key":"929_CR123","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.biopsych.2013.12.015","volume":"78","author":"RL Carhart-Harris","year":"2015","unstructured":"Carhart-Harris RL, Murphy K, Leech R, Erritzoe D, Wall MB, Ferguson B, et al. The effects of acutely administered 3,4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen level-dependent resting state functional connectivity. Biol Psychiatry. 2015;78:554\u201362.","journal-title":"Biol Psychiatry"},{"key":"929_CR124","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1017\/S003329171700263X","volume":"48","author":"MK Dahlgren","year":"2018","unstructured":"Dahlgren MK, Laifer LM, VanElzakker MB, Offringa R, Hughes KC, Staples-Bradley LK, et al. Diminished medial prefrontal cortex activation during the recollection of stressful events is an acquired characteristic of PTSD. Psychol Med. 2018;48:1128\u201338.","journal-title":"Psychol Med"},{"key":"929_CR125","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","volume":"236","author":"MC Mithoefer","year":"2019","unstructured":"Mithoefer MC, Feduccia AA, Jerome L, Mithoefer A, Wagner M, Walsh Z, et al. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology. 2019;236:2735\u201345.","journal-title":"Psychopharmacology"},{"key":"929_CR126","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","volume":"27","author":"JM Mitchell","year":"2021","unstructured":"Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021;27:1025\u201333.","journal-title":"Nat Med"},{"key":"929_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2147","author":"K Sogo","year":"2021","unstructured":"Sogo K, Sogo M, Okawa Y. Centrally acting anticholinergic drug trihexyphenidyl is highly effective in reducing nightmares associated with post-traumatic stress disorder. Brain Behav. 2021. https:\/\/doi.org\/10.1002\/brb3.2147.","journal-title":"Brain Behav"},{"key":"929_CR128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1176\/jnp.2007.19.1.92","volume":"19","author":"RN McLay","year":"2007","unstructured":"McLay RN, Ho J. Posttraumatic stress disorder-like symptoms after treatment with acetylcholinesterase inhibitors. J Neuropsych Clin Neuroschience. 2007;19:92\u20133.","journal-title":"J Neuropsych Clin Neuroschience."},{"key":"929_CR129","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2019-0196","author":"H Kaur","year":"2020","unstructured":"Kaur H, Kaur R, Jaggi AS, Bali A. Beneficial role of central anticholinergic agent in preventing the development of symptoms in mouse model of post-traumatic stress disorder. J Basic Clin Physiol Pharmacol. 2020. https:\/\/doi.org\/10.1515\/jbcpp-2019-0196.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"929_CR130","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1176\/appi.ajp.161.8.1488","volume":"161","author":"A Aerni","year":"2004","unstructured":"Aerni A, Traber R, Hock C, Roozendaal B, Schelling G, Papassotiropoulos A, et al. Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry. 2004;161:1488\u201390.","journal-title":"Am J Psychiatry"},{"key":"929_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0673-5","author":"L Astill Wright","year":"2019","unstructured":"Astill Wright L, Sijbrandij M, Sinnerton R, Lewis C, Roberts NP, Bisson JI. Pharmacological prevention and early treatment of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis. Transl Psychiatry. 2019. https:\/\/doi.org\/10.1038\/s41398-019-0673-5.","journal-title":"Transl Psychiatry"},{"key":"929_CR132","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.7205\/MILMED-D-16-00010","volume":"182","author":"AJ Phelps","year":"2017","unstructured":"Phelps AJ, Varker T, Metcalf O, Dell L. What are effective psychological interventions for veterans with sleep disturbances? A rapid evidence assessment. Mil Med. 2017;182:1541\u201350.","journal-title":"Mil Med"},{"key":"929_CR133","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/jclp.21970","volume":"69","author":"SO Margolies","year":"2013","unstructured":"Margolies SO, Rybarczyk B, Vrana SR, Leszczyszyn DJ, Lynch J. Efficacy of a cognitive-behavioral treatment for insomnia and nightmares in Afghanistan and Iraq Veterans with PTSD. J Clin Psychol. 2013;69:1026\u201342.","journal-title":"J Clin Psychol"},{"key":"929_CR134","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jts.22306","volume":"31","author":"G Belleville","year":"2018","unstructured":"Belleville G, Dub\u00e9-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018;31:591\u2013601.","journal-title":"J Trauma Stress"},{"key":"929_CR135","unstructured":"Tran K, Moulton K, Santesso N, Rabb D. Cognitive processing therapy for post-traumatic stress disorder: a systemic review and meta-analysis. CADTH Health Technol Assess. 2016;141.(CADTH health technology assessment; no. 141)."},{"key":"929_CR136","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s41782-021-00126-8","volume":"5","author":"J Szab\u00f3","year":"2021","unstructured":"Szab\u00f3 J, T\u00f3th S. Collision every night: treating nightmares with trauma-focused methods: case report. Sleep Vigil. 2021;5:151\u20136.","journal-title":"Sleep Vigil."},{"key":"929_CR137","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jts.2490080212","volume":"8","author":"SM Silver","year":"1995","unstructured":"Silver SM, Brooks A, Obenchain J. Treatment of Vietnam War veterans with PTSD: a comparison of eye movement desensitization and reprocessing, biofeedback, and relaxation training. J Trauma Stress. 1995;8:337\u201342.","journal-title":"J Trauma Stress"},{"key":"929_CR138","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1037\/drm0000021","volume":"26","author":"C Schubert","year":"2016","unstructured":"Schubert C, Punamaki R. Posttraumatic nightmares of traumatized refugees: dream work integrating cultural values work. Dreaming. 2016;26:10\u201328.","journal-title":"Dreaming"},{"key":"929_CR139","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/hup.2522","volume":"31","author":"G Lipinska","year":"2016","unstructured":"Lipinska G, Baldwin DS, Thomas KGF. Pharmacology for sleep disturbance in PTSD. Hum Psychopharmacol Clin Exp. 2016;31:156\u201363.","journal-title":"Hum Psychopharmacol Clin Exp"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-022-00929-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-022-00929-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-022-00929-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T18:15:45Z","timestamp":1700676945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-022-00929-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":139,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1007\/s40263-022-00929-x","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"16 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None of the authors have any conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors participated in producing this article: CG performed the literature search and drafted the article, LLvdH and PS assisted with drafting and critically revising, and SS had the idea for the article and critically revised the work. All authors read and approved the manuscript and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}